Loading
Latest filing published 14 Aug 2023 for Vincerx Pharma, Inc., €9,077.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Alexander A. Seelenberger (finance chief) discloses dealings in Vincerx Pharma, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 29 June 2021 to 11 August 2023.
On the market, this insider has only ever bought: 3 purchases, €115k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2023 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €22k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 14 August 2023 with an open-market purchase (€9,077) in Vincerx Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations